Leadership Overview
Neogen has 4 executives leading key functions including finance, human resources, and operations.
Driven by a commitment to safety, Neogen is dedicated to developing and marketing essential products for food and animal safety worldwide, impacting global health through rigorous scientific solutions.
Driven by a commitment to safety, Neogen is dedicated to developing and marketing essential products for food and animal safety worldwide, impacting global health through rigorous scientific solutions.
Leadership Roles at Neogen
Bryan Riggsbee - Chief Financial Officer
Bryan Riggsbee, the Chief Financial Officer at Neogen, directs all financial operations and strategic fiscal planning. Riggsbee oversees budgeting, forecasting, and resource allocation, ensuring robust financial health across the organization. This leadership role involves managing investor relations and capital management, critical for funding Neogen's global expansion and research initiatives. By optimizing financial strategies, Bryan Riggsbee directly supports the company's mission to enhance food and animal safety through innovative product development. The Chief Financial Officer's oversight extends to financial reporting and compliance, maintaining transparency and accountability in all fiscal matters. Riggsbee's expertise is vital for navigating complex market dynamics and driving sustainable growth for Neogen Corporation.
Daniel Kruh - President
Daniel Kruh, the President at Neogen, drives operational excellence and strategic growth across key business segments. Kruh oversees the execution of company-wide initiatives, ensuring alignment with Neogen's commitment to food and animal safety. This leadership position involves managing cross-functional teams to deliver innovative diagnostic kits and safety products to global markets. By focusing on market penetration and product development, Daniel Kruh enhances Neogen's competitive advantage. The President's purview includes optimizing supply chain logistics and ensuring efficient product delivery worldwide. Kruh's strategic vision is instrumental in expanding Neogen's reach and reinforcing its reputation as a leader in safety solutions.
C. Donovan - President
C. Donovan, the President at Neogen, spearheads strategic development and market expansion initiatives. Donovan directs efforts to enhance Neogen's product portfolio, focusing on advancements in both food and animal safety sectors. This executive role involves fostering key partnerships and exploring new market opportunities to drive revenue growth. By championing innovation, C. Donovan ensures Neogen remains at the forefront of safety technology. The President's responsibilities encompass overseeing research and development pipelines and ensuring the successful commercialization of new products. Donovan's leadership is critical for navigating the evolving landscape of global safety regulations and consumer demands, solidifying Neogen's market position.
Kevin Burke - Chief Human Resources Officer
Kevin Burke, the Chief Human Resources Officer at Neogen, architects the company's talent strategy and organizational development. Burke leads initiatives focused on employee engagement, recruitment, and retention, fostering a culture that supports Neogen's mission. This executive role involves developing comprehensive HR policies and programs that align with business objectives and promote a productive work environment. Overseeing workforce planning, Kevin Burke ensures the company has the skilled personnel necessary to drive innovation in food and animal safety solutions. The Chief Human Resources Officer's responsibilities include managing compensation and benefits, and championing diversity and inclusion across all departments. Burke's strategic direction is fundamental to building and sustaining a high-performing team dedicated to Neogen's global impact.
Explore Leadership Teams in Manufacturing
Amrutanjan Health Care Ltd specializes in pain and congestion management products, including aromatic balms, roll-ons, and sprays. Founded in 1893, the company is dedicated to enhancing people's well-being by combining natural extracts with scientific research to create effective, side-effect-free solutions. Their product range caters to various needs, including headache relief, body pain management, and women's hygiene. Amrutanjan aims to serve a global consumer base while maintaining a commitment to sustainability and social responsibility.
Company Leadership PD
MB
TJ
SN
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership DR
RK
NY
SD
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Company Leadership SG
CJ
JB
EL
Alkermes plc is a global biopharmaceutical enterprise that specialises in developing and commercialising innovative medicines for people living with complex psychiatric and neurological disorders. Headquartered in Dublin, Ireland, the company combines deep neuroscience expertise with patient‑inspired science to pursue treatments for conditions such as addiction, schizophrenia, bipolar disorder, opioid dependence and other central nervous system diseases. Its approach integrates scientific research, clinical development and specialised commercial infrastructure to deliver both marketed medicines and investigational candidates, aiming to address serious unmet medical needs and improve how chronic neurological and mental health conditions are managed.
Company Leadership
SS

JS